Nadolol (Cipla USA Inc.)
Welcome to the PulseAid listing for the Nadolol drug offered from Cipla USA Inc.. This Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Cipla USA Inc. |
| NON-PROPRIETARY NAME: | Nadolol |
| SUBSTANCE NAME: | NADOLOL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-02-23 |
| END MARKETING DATE: | 0000-00-00 |
Nadolol HUMAN PRESCRIPTION DRUG Details:
| Item Description | Nadolol from Cipla USA Inc. |
| LABELER NAME: | Cipla USA Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20(mg/1) |
| START MARKETING DATE: | 2016-02-23 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69097-867_4d401693-53ab-4d63-9f25-39fe5ddca2a1 |
| PRODUCT NDC: | 69097-867 |
| APPLICATION NUMBER: | ANDA203455 |
Other NADOLOL Pharmaceutical Manufacturers / Labelers:
